IntelliPharmaCeutics International (IntelliPharmaCeutics International) Institutional Ownership : 0.63% (As of Apr. 27, 2024)

View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IntelliPharmaCeutics International's institutional ownership is 0.63%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IntelliPharmaCeutics International's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IntelliPharmaCeutics International's Float Percentage Of Total Shares Outstanding is 98.25%.

IntelliPharmaCeutics International Institutional Ownership Historical Data

The historical data trend for IntelliPharmaCeutics International's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Institutional Ownership Chart

IntelliPharmaCeutics International Historical Data

The historical data trend for IntelliPharmaCeutics International can be seen below:

	2019-02-28	2020-03-31	2020-04-30	2020-05-31	2020-06-30	2020-07-31	2020-08-31	2020-09-30	2020-10-31	2020-11-30
Institutional Ownership	0.82	0.70	0.70	0.70	0.65	0.63	0.63	0.63	0.63	0.63

IntelliPharmaCeutics International Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.